台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

NDP019: Hyperglycemia and risk of progression to castration-resistance in men with metastatic hormone sensitive prostate cancer

2021-05-24 • 觀看: 1264 • 回應: 0 • doc
NDP018: Rare primary large-cell neuroendocrine carcinoma of the urinary bladder: A case report and literature review

2021-05-24 • 觀看: 1238 • 回應: 0 • doc
NDP017: A real-world experience of using Abiraterone acetate in the treatment of metastatic castration sensitive prostate cancer

2021-05-24 • 觀看: 1371 • 回應: 0 • doc
NDP016: Radium-223 injection for more then 3 courses improves survival in patients with metastatic castration-resistant prostate cancer

2021-05-24 • 觀看: 1390 • 回應: 0 • doc
NDP015: Primary small cell neuroendocrine carcinoma of the urinary bladder: Case report and review of the literature

2021-05-24 • 觀看: 1227 • 回應: 0 • doc
NDP014: Rare renal tumor: MiT family translocation renal cell carcinoma

2021-05-24 • 觀看: 1392 • 回應: 0 • doc
NDP013: IgG4-related disease with ureteropelvic junction tumor: A case report

2021-05-24 • 觀看: 1337 • 回應: 0 • doc
NDP012: Cases Report: Huge cystic non-clear cell renal cell carcinoma with duodenum, ascending and transverse colon invasion associated with peritonitis

2021-05-24 • 觀看: 1316 • 回應: 0 • doc
NDP011: Retroperitoneal mucinous cystadenoma with neuroendocrine features: a case report and review of the literature

2021-05-24 • 觀看: 1442 • 回應: 0 • doc
NDP010: Chondroma of the urinary bladder: A case report

2021-05-24 • 觀看: 1246 • 回應: 0 • doc
NDP009: Metastatic INI1-deficient and succinate dehydrogenase B-deficient renal cell carcinoma treated with presurgical Pembolizumab/Axitinib followed by consolidative nephrectomy: a case report

2021-05-24 • 觀看: 1281 • 回應: 0 • doc
NDP008: Metastatic papillary renal cell carcinoma without primary renal tumor: treatment experience and follow up

2021-05-24 • 觀看: 1272 • 回應: 0 • doc

Prev
555
556
557
558
559
560
561
562
563
564
Next
/ 1134